Lu AF11167
Lu AF11167 is a pharmaceutical drug with 5 clinical trials. Historical success rate of 80.0%.
Success Metrics
Based on 4 completed trials
Phase Distribution
Phase Distribution
4
Early Stage
1
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
80.0%
4 of 5 finished
20.0%
1 ended early
0
trials recruiting
5
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Flexible-dose Long-term Extension Study of Lu AF11167 in Patients With Schizophrenia With Prominent Negative Symptoms
A Study Investigating Tablet Formulations of Lu AF11167 in Healthy Subjects
Study to Evaluate the Effect of a Known and Marketed Product, Itraconazole (Mycosis Treatment) on Lu AF11167 Entering the Body and Subsequently Elimination. The Study is a Drug-drug Interaction Study in Healthy Volunteers.
Pharmacokinetic Properties of Various Modified Release Tablet Formulations of Lu AF11167
Safety and Tolerability Study of Lu AF11167 After Repeated Dosing in Patients With Schizophrenia
Clinical Trials (5)
Flexible-dose Long-term Extension Study of Lu AF11167 in Patients With Schizophrenia With Prominent Negative Symptoms
A Study Investigating Tablet Formulations of Lu AF11167 in Healthy Subjects
Study to Evaluate the Effect of a Known and Marketed Product, Itraconazole (Mycosis Treatment) on Lu AF11167 Entering the Body and Subsequently Elimination. The Study is a Drug-drug Interaction Study in Healthy Volunteers.
Pharmacokinetic Properties of Various Modified Release Tablet Formulations of Lu AF11167
Safety and Tolerability Study of Lu AF11167 After Repeated Dosing in Patients With Schizophrenia
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5